Sunshine Biopharma Inc. Increase (Decrease) in Other Accounts Payable
Sunshine Biopharma Inc. (SBFM) reported Increase (Decrease) in Other Accounts Payable of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-05-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayable · last filed 2020-05-01
- Sunshine Biopharma Inc. increase (decrease) in other accounts payable for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Sunshine Biopharma Inc. increase (decrease) in other accounts payable for fiscal 2018 was $36.50K.
- Sunshine Biopharma Inc. increase (decrease) in other accounts payable for fiscal 2017 was $0.00.
| Period end | Increase (Decrease) in Other Accounts Payable 12 month |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-05-01 |
| 2018-12-31 | $36.50K 10-K · filed 2020-05-01 |
| 2017-12-31 | $0.00 10-K · filed 2019-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |